Literature DB >> 26913561

Methylprednisolone for the Treatment of Patients with Acute Spinal Cord Injuries: A Propensity Score-Matched Cohort Study from a Canadian Multi-Center Spinal Cord Injury Registry.

Edward D Hall1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26913561     DOI： 10.1089/neu.2016.4473

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN： 0897-7151            Impact factor:   5.269


× No keyword cloud information.
  4 in total

Review 1.  Clinical Trials in Traumatic Spinal Cord Injury.

Authors:  Jayne Donovan; Steven Kirshblum
Journal:  Neurotherapeutics       Date:  2018-07       Impact factor: 7.620

Review 2.  Perinatal hypoxic-ischemic damage: review of the current treatment possibilities.

Authors:  A Frajewicki; Z Laštůvka; V Borbélyová; S Khan; K Jandová; K Janišová; J Otáhal; J Mysliveček; V Riljak
Journal:  Physiol Res       Date:  2020-12-31       Impact factor: 1.881

3.  Therapeutic implications of advanced age at time of spinal cord injury.

Authors:  Andrew N Stewart; John C Gensel; Bei Zhang
Journal:  Neural Regen Res       Date:  2019-11       Impact factor: 5.135

4.  Methylprednisolone Reduces Persistent Post-ischemic Inflammation in a Rat Hypoxia-Ischemia Model of Perinatal Stroke.

Authors:  Svetlana Altamentova; Prakasham Rumajogee; James Hong; Stephanie R Beldick; Sei Joon Park; Albert Yee; Michael G Fehlings
Journal:  Transl Stroke Res       Date:  2020-03-05       Impact factor: 6.800
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.